Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study-Reference-Cited by-同舟云学术

Association of Seropositivity and Mortality in Rheumatoid Arthritis and the Impact of Treatment With Disease‐Modifying Antirheumatic Drugs: Results From a Real‐World Study

Published:2020-01-13 Issue:2 Volume:72 Page:176-183
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Alemao Evo¹^ORCID,Bao Ying¹,Weinblatt Michael E.²,Shadick Nancy²

Affiliation:

1. Bristol‐Myers Squibb Princeton New Jersey

2. Brigham and Women's Hospital Boston Massachusetts

Funder

Bristol-Myers Squibb

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24071

Reference29 articles.

1. Rheumatoid arthritis

2. Rheumatoid factors antedating clinical rheumatoid arthritis;Aho K;J Rheumatol,1991

3. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process;Aho K;J Rheumatol,1993

4. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors

5. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry;Arthritis Research & Therapy;2024-07-26

2. Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry;2024-03-12

3. Autoantibody-negative rheumatoid arthritis: still a challenge for the rheumatologist;The Lancet Rheumatology;2023-12

4. Subcutaneous abatacept for the treatment of rheumatoid arthritis in routine clinical practice in Germany, Austria, and Switzerland: 2-year retention and efficacy by treatment line and serostatus;Clinical Rheumatology;2023-06-14

5. Geographic Variation in Disease Burden and Mismatch in Care of Patients With Rheumatoid Arthritis in the United States;ACR Open Rheumatology;2023-02-21